This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Daniel Fernando, PhD
West Paterson, NJ

JAMA. 1992;267(10):1340.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The article by Nelson et al¹ raises the issue of prevention of human immunodeficiency virus (HIV) infection in intravenous drug users (IVDUs) in the United States by giving them access to sterile injection equipment. All western European countries (except Sweden) and Australia have liberalized needle access policies as a specific strategy for HIV prevention among IVDUs.² Given the high incidence of HIV among IVDUs, restrictive needle access policies in the United States have had a negative impact on HIV prevention.

The authors conclude: "Our data, derived from a 'natural experiment,' provide some evidence to suggest that access to sterile injection equipment might lead to lower rates of HIV infection among IV drug users." Nevertheless, it must be emphasized that their tentative "suggestion" is based on the erroneous conceptualization of "needle sharing" current in the United States. On the basis of my ethnographic research among IVDUs, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?